Advanced SearchSearch Tips
In Vitro Stability of Liposomes Containing Newly Synthesized Glycolipid
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
In Vitro Stability of Liposomes Containing Newly Synthesized Glycolipid
Song, Chung-Kil; Jung, Soon-Hwa; Seong, Ha-Soo; Cho, Sun-Hang; Shin, Byung-Cheol;
  PDF(new window)
Liposomes having particle size from several tens to hundreds nanometers are efficient carriers for injectable drug delivery. Enhancement of liposome stability in bloodstream has been studied because of its relatively short circulation time and fast clearance from human body by reticuloendothelial system (RES) in blood vessel. In this study, new disaccharide-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) derivatives in which lactose or sucrose as the disaccharide molecule was conjugated covalently to DSPE were synthesized. Liposomes of which surface had disaccharide molecules were prepared by incorporating the disaccharide-DSPE into liposomes as one of their lipid components. Particle size of the prepared liposomes was approximately 100 nm. The liposomes of which surface were modified with the disaccharide-DSPE showed -25 mV of zeta potential value due to the presence of hydroxyl groups on their surface, while the unmodified control liposomes showed -10 mV of zeta potential value. Loading efficiency of model drug, doxorubicin, into liposomes was about 90%. Stability of the disaccharide-modified liposomes in vitro was evaluated by monitoring the amount of protein adsorption and particle size of the liposomes in serum. Disaccharide-modified liposomes were more stable in serum than unmodified control liposomes or polyethyleneglycol (PEG)-modified liposomes due to less adsorption of serum protein and hence less increase of their particle size. The liposomes of which surface was modified with disaccharide-DSPE conjugate can be used as long-circulating carriers for drugs having high toxicity or short half-life time due to their enhanced stability in blood circulatory system.
 Cited by
Bangham, A. D.; Standish, M. M.; Watkis, J. C. J. Mol. Biol. 1965, 13, 238 crossref(new window)

Allen, T. M.; Moase E. H. Adv. Drug Delivery. Rev. 1996, 21, 117 crossref(new window)

Sharma, A.; Sharma, U. S. Int. J. Pharm. Biopharm. 1997, 154, 123 crossref(new window)

Van Slooten, M. L.; Boerman O.; Romoren, K.; Kedar, E.; Crommelin, D. J. A.; Storm, G. Biochim. Biophys. Acta 2001, 1530, 134 crossref(new window)

Torchilin, V. P. Nat. Rev. Drug Discov. 2005, 4, 145 crossref(new window)

Moghimi, S. M.; Szebeni, J. Prog. Lipid Res. 2003, 42, 463 crossref(new window)

Liu, D. Adv. Drug Delivery. Rev. 1997, 24, 201 crossref(new window)

Vertut-Doi, A.; Ishiwata, H.; Miyajima, K. Biochim. Biophys. Acta 1996, 1278, 19

Song, C. K.; Hwang, T.; Seong, H.; Park, E. S.; Shin B. C. J. Kor. Pharm. Sci. 2006, 50, 216 crossref(new window)

Albert, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K. Walter, P. Molecular Biology of the Cell, fourth ed., Garland Science, New York, 2002, p 612

Medda, S.; Mukherjee, S.; Das, N.; Naskar, K.; Mahato, S. B.; Basu, M. K. Biotechnol. Appl. Biochem. 1993, 17, 37

Xu, Z.; Jayaseharan, J.; Marchant, R. E. J. Colloid Interface Sci. 1996, 118, 6101

Cansell, M.; Parisel, C.; Jozefonvicz, J.; Letourneur, D. J. Biomed. Mater. Res. 1999, 44, 140 crossref(new window)

Allen, T. M.; Hansen, C.; Rutledge, J. Biochim. Biophys. Acta 1989, 981, 27 crossref(new window)

Varshney, V. K.; Gupta, P. K; Naithani, S.; Khullar, R.; Bhatt, A.; Soni, P. L. Carbohyd. Polym. 2006, 63, 40 crossref(new window)

Heinze, T.; Pfeiffer, K. Macromol. Mater. Eng. 1999, 266, 37

Haran, G.; Cohen, R.; Bar, L. K.; Barenholz, Y. Biochim. Biophys. Acta 1993, 1151, 201 crossref(new window)

Baumgarten, H. J. Immunol. Methods 1985, 82(1), 25 crossref(new window)